Cleared Traditional

K934539 - THE YELLOW IRIS URINALYSIS WORKSTATION WITH IRISCOPE BODY FLUID ANALYSIS CAPABILITY

K934539 is an FDA 510(k) clearance for THE YELLOW IRIS URINALYSIS WORKSTATION ..., manufactured by Intl. Remote Imaging Systems. The device is a Class 2 Microbiology device with product code GKL cleared through the Traditional 510(k) pathway after a 194-day FDA review.

K934539 · Intl. Remote Imaging Systems · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1994
Decision
194d
Days
Class 2
Risk

K934539 is an FDA 510(k) clearance for the THE YELLOW IRIS URINALYSIS WORKSTATION WITH IRISCOPE BODY FLUID ANALYSIS CAPA.... Classified as Counter, Cell, Automated (particle Counter) (product code GKL), Class II - Special Controls.

Submitted by Intl. Remote Imaging Systems (Chatsworth, US). The FDA issued a Cleared decision on March 30, 1994 after a review of 194 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 864.5200 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Intl. Remote Imaging Systems devices

FDA 510(k) Submission Details - K934539

510(k) Number K934539 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 1993
Decision Date March 30, 1994
Days to Decision 194 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 102d · This submission: 194d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKL Device Classification - Class 2, Special Controls

Product Code GKL Counter, Cell, Automated (particle Counter)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GKL Counter, Cell, Automated (particle Counter)

All 98
Devices cleared under the same product code (GKL) and FDA review panel - the closest regulatory comparables to K934539.
RETICULOCYTE METHOD
K954607 · Bayer Corp. · Aug 1996
YELLOW IRIS URINALYSIS WORKSTATION W/IRISCOPE BODY FLUID ANALYSIS CAPABILITY
K954006 · Intl. Remote Imaging Systems · Mar 1996
COULTER Z 1
K952308 · Coulter Corp. · Oct 1995
TECHNICON H* 3TM RTC SYSTEM (IN-VITRO DIAG.SYST.)
K930685 · Heraeus Kulzer, Inc. · Jun 1993
QBC HEMACAN HEMATOLOGY SYSTEM
K923121 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1992
SYSMEX(TM) R-3000 AUTOMATED RETICULOCYTE ANALYZER
K912494 · Toa Medical Electronics USA, Inc. · Sep 1991